Dr Zhomart Orman is a Research Fellow at the Australian and New Zealand Intensive Care Research Centre (ANZIC-RC), Monash University. His research focuses on economic evaluations in intensive care setting, with a particular emphasis on model-based and trial-based cost-effectiveness analyses. Currently, he is evaluating the cost-effectiveness of cryopreserved platelets versus conventional liquid-stored platelets in managing active surgical bleeding. 

Zhomart holds a Doctor of Medicine from Kazakh National Medical University in Kazakhstan, a Master of Science in Public Health from Heidelberg University in Germany, and a PhD from Monash University in Australia. His doctoral research at the Stroke and Ageing Research Group, Monash Health, provided novel insights into the cost-effectiveness of government-funded chronic disease management policies in primary care for survivors of stroke, using patient-reported trial data and linked administrative datasets.

With a diverse background in clinical medicine and global health, Zhomart has worked as an emergency department clinician in Kazakhstan and participated in various international projects with the World Bank and the World Health Organization. His efforts have significantly contributed to the global promotion of primary health care and the movement towards universal health coverage.